Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | GILDGilead Sciences, Inc. | NVSNovartis AG |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | Switzerland |
| Market cap | $212B | $308B |
| Price | $170.87 | $163.26 |
| Last day | +0.92% | −0.26% |
, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.
GILD analysis and Q-Scores →Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.